Merck, a leading science and technology company, opened its new Metrology & Inspection site in Saint-Ismier, France. The €20 million, 4,500 m² site strengthens Merck's capacity to develop and manufacture precise metrology and inspection tools to address the growing demands of the semiconductor industry for high-pe…
ICON plc , a world-leading clinical research organisation, announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas, as well as new satellite outpatient clinics in Houston, Texas and Lawrence, Kansas. These new, purpose-built…
Niowave announced the groundbreaking of a new $75 million production facility in Lansing, Michigan, significantly expanding its manufacturing footprint and strengthening domestic supply of Actinium‑225 (Ac‑225), a critical isotope used in next‑generation targeted cancer therapies. The new site, Niowave's second dedic…
FUJIFILM Cellular Dynamics Inc., a pioneering global developer and manufacturer of human-induced pluripotent stem cells celebrated the opening of its new headquarters and iPSC development and manufacturing facility in its Madison home. The new site is expected to quadruple the capacity for the company’s iPSC-based re…
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., has officially unveiled a new, state-of-the-art payload-linker development and manufacturing suite at its Riverview, Michigan drug substance facility. This launch is a key element of t…
Kyowa Kirin Co., Ltd. announced that it plans to create a state-of-the-art research hub, to further improve its capabilities in drug discovery. The plan is to integrate two existing sites, the Fuji Site (Fuji Research Park [FRP]; Research Park Head: Satoshi Saeki / CMC R&D Center; Center Head: Hideo Takashima, Nag…
Novartis, a leading global innovative medicines company, broke ground on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the latest milestone in its broader $23 billion investment in US manufacturing and research. The start of construction on the company’s first Texas‑based manufac…
Eli Lilly and Company announced an additional $4.5 billion investment across two of its three Lebanon sites—bringing the company's total Indiana capital expansion commitments since 2020 to more than $21 billion. Lilly's evolving pipeline, as well as anticipated demand for its medicines, prompted this additional commit…
TerraPower Isotopes® (TPI), part of TerraPower, a nuclear innovation company that advances transformative technologies across both energy and healthcare, broke ground on its flagship Bellwether Laboratory—a 250,000-square-foot actinium-225 (Ac-225) manufacturing facility located in the Bellwether District of Philadelp…
Amgen announced plans to invest an additional $300 million in its U.S. manufacturing network to further advance U.S.-based production capacity, enhance next-generation technologies and support a reliable supply of medicines for patients. "Amgen has been a leader in U.S. biomanufacturing for decades, and this expansio…
Page 5 of 58